Zacks Research Has Pessimistic View of VMRK Q3 Earnings

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) – Research analysts at Zacks Research reduced their Q3 2026 EPS estimates for Vivmark Residential Common Shares of Beneficial Interest in a research note issued to investors on Wednesday, August 12th. Zacks Research analyst Team now expects that the company will post earnings of $1.02 per share for the quarter, down from their prior estimate of $1.03. Zacks Research also issued estimates for Vivmark Residential Common Shares of Beneficial Interest’s FY2026 earnings at $4.07 EPS, Q1 2027 earnings at $1.02 EPS, Q2 2027 earnings at $1.03 EPS, Q3 2027 earnings at $1.07 EPS, Q4 2027 earnings at $1.09 EPS, FY2027 earnings at $4.21 EPS, Q1 2028 earnings at $1.06 EPS and FY2028 earnings at $4.40 EPS.

Several other brokerages also recently issued reports on VMRK. Stifel Nicolaus lowered their price target on Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating on the stock in a research report on Wednesday. Evercore assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday. They set an “in-line” rating and a $72.00 target price for the company. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.25.

Vivmark Residential Common Shares of Beneficial Interest Trading Up 0.2%

NYSE:VMRK traded up $0.10 during midday trading on Wednesday, reaching $64.13. The stock had a trading volume of 3,178,852 shares, compared to its average volume of 2,991,701. Vivmark Residential Common Shares of Beneficial Interest has a 1-year low of $57.57 and a 1-year high of $71.50.

Vivmark Residential Common Shares of Beneficial Interest News Roundup

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

• Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and continues to see substantial upside, although it modestly reduced its price target to $78.50 from $79.00. Benzinga report
• Positive Sentiment: Zacks Research slightly raised its FY2026 EPS estimate to $4.07 from $4.06, its FY2027 forecast to $4.21 from $4.20, and its Q1 2027 estimate to $1.02 from $1.00. These upward revisions provide limited support for the shares.
• Neutral Sentiment: Evercore initiated coverage with an “in-line” rating and a $72 price target, implying potential appreciation but signaling that the analyst views the stock as fairly valued relative to its outlook. TickerReport coverage article
• Negative Sentiment: Zacks Research lowered several forecasts, including Q3 2026 EPS to $1.02 from $1.03, Q1 2028 EPS to $1.06 from $1.08, Q2 2027 EPS to $1.03 from $1.04, Q3 2027 EPS to $1.07 from $1.09, and FY2028 EPS to $4.40 from $4.43. The reductions suggest some pressure on medium- and long-term earnings expectations.

About Vivmark Residential Common Shares of Beneficial Interest

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.